Key Highlights
- CrowdStrike enhanced its share repurchase authorization by an additional $500M, pushing total approved buybacks to $1.5 billion.
- CRWD shares began Monday trading at $399.12 with a market capitalization approaching $101.2 billion.
- Morgan Stanley elevated CRWD to Overweight status with a $510 price objective; consensus analyst target hovers around ~$505.
- Institutional ownership represents 71.16% of outstanding shares; company insiders disposed of approximately 68,636 shares valued at $28.7M over the previous quarter.
- Fourth-quarter revenue reached $1.31B, representing a 23.8% year-over-year increase and surpassing projections by roughly $10M.
CrowdStrike (CRWD) commenced Monday’s session at $399.12, substantially beneath its 52-week peak of $566.90.
CrowdStrike Holdings, Inc., CRWD
CrowdStrike revealed Monday that it’s amplifying its stock buyback initiative by $500 million, elevating the complete authorization to $1.5 billion. The cybersecurity firm has previously repurchased 413,130 Class A ordinary shares at a mean price of $364.57, representing total expenditures of $150.6 million under the current program.
Chief Financial Officer Burt Podbere connected the decision to the firm’s extended-term objective of achieving $20 billion in annual recurring revenue by fiscal 2036. “We have elevated our share repurchase authorization to $1.5 billion to strategically return value to shareholders,” Podbere noted.
The disclosure arrives as CRWD exchanges hands approximately 30% beneath its 52-week pinnacle, a decline partially attributed to an industry-wide downturn following worries that sophisticated AI technologies might supplant certain security capabilities.
The equity’s 50-day moving average rests at $411.92, whereas the 200-day moving average stands at $467.32 — both positioned above the stock’s present trading level.
Wall Street Maintains Optimistic Outlook
Analyst perspectives remain predominantly favorable. Morgan Stanley elevated CRWD from equal weight to overweight during March, boosting its price objective from $487 to $510. Truist maintains a buy designation with a $550 target, while Daiwa carries an outperform recommendation with a $500 objective. The consensus analyst price target registers at approximately $504.98, with an overall “Moderate Buy” rating across 51 analysts.
One analyst maintains a strong buy recommendation, 34 hold buy ratings, 15 stand at hold, and one carries a sell designation.
Runnymede Capital Advisors established a fresh position during Q4, acquiring 3,160 shares valued at roughly $1.48 million. Multiple additional institutional investors also expanded their holdings in recent quarters, including Carnegie Investment Counsel and Traynor Capital Management.
Zacks Research elevated CRWD from strong sell to hold during March, and the organization exceeded Q4 earnings projections — delivering $1.12 EPS compared to a consensus estimate of $1.10, with revenue of $1.31 billion versus anticipated $1.30 billion.
Executive Share Disposals Persist
Conversely, insider share sales have remained consistent. Chief Executive Officer George Kurtz disposed of 28,853 shares in early February at a mean price of $413.01, generating approximately $11.9 million. This transaction diminished his stake by 1.38%, leaving him with roughly 2.05 million shares.
President Michael Sentonas liquidated 19,367 shares in late March at $411.06, amounting to approximately $7.96 million. Collectively, company insiders have sold roughly 68,636 shares valued at $28.7 million throughout the past 90 days. Insider ownership currently represents about 3.32% of the corporation.
CrowdStrike has also recently enhanced its GovCloud platform and introduced a CTEM service in partnership with HCLTech, both designed to expand its enterprise and government-sector client portfolio.
The stock maintains a 52-week floor of $298.00 and a 52-week ceiling of $566.90. Wall Street analysts project EPS of $0.55 for the ongoing fiscal year.


